Cystatin C in Cerebrospinal Fluid is Upregulated in Elderly Patients With Chronic Osteoarthritis Pain and Modulated Through Matrix Metalloproteinase 9–Specific Pathway

2014 ◽  
Vol 30 (4) ◽  
pp. 331-339 ◽  
Author(s):  
Shu-Lin Guo ◽  
Cheng-Ta Han ◽  
Jiun-Lung Jung ◽  
Wei-Jung Chen ◽  
John Jian-Feng Mei ◽  
...  
Cytokine ◽  
2010 ◽  
Vol 51 (3) ◽  
pp. 294-297 ◽  
Author(s):  
Oranuch Sanpool ◽  
Pewpan M. Intapan ◽  
Tongjit Thanchomnang ◽  
Taweesak Santivarangkana ◽  
Kanigar Niwattayakul ◽  
...  

2017 ◽  
Vol 63 (1) ◽  
pp. 29-33
Author(s):  
AYAKO TSUMITA ◽  
KAORU OBINATA ◽  
SHIGEAKI INOUE ◽  
TOMOYUKI NAKAZAWA ◽  
KENICHIRO KANEKO ◽  
...  

2000 ◽  
Vol 110 (1-2) ◽  
pp. 244-251 ◽  
Author(s):  
Maryna Yushchenko ◽  
Frank Weber ◽  
Michael Mäder ◽  
Ulrike Schöll ◽  
Malgorzata Maliszewska ◽  
...  

2002 ◽  
Vol 186 (11) ◽  
pp. 1692-1695 ◽  
Author(s):  
Paul L. Williams ◽  
Stephen L. Leib ◽  
Perparim Kamberi ◽  
David Leppert ◽  
Raymond A. Sobel ◽  
...  

2015 ◽  
Vol 53 (7) ◽  
pp. 2340-2342 ◽  
Author(s):  
Irmeli Roine ◽  
Tuula Pelkonen ◽  
Anneli Lauhio ◽  
Maija Lappalainen ◽  
Manuel Leite Cruzeiro ◽  
...  

We explored the changes of the initially highly upgraded cerebrospinal fluid matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of MMP 1 (TIMP-1) response during recovery of childhood bacterial meningitis and their association with outcome. The sizes of these changes varied substantially, but a steeper decrease in the MMP-9 and an increase of the TIMP-1 concentrations augured a better outcome.


Sign in / Sign up

Export Citation Format

Share Document